API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Propranolol Hydrochloride: Sedative-Sparing Efficacy & PTSD Intervention Potential

Propranolol hydrochloride reduces sedative doses in ventilated patients and alleviates PTSD physiological symptoms with limited evidence for broad efficacy.

Jan 26,2026  API

Benzhexol Hydrochloride: Efficacy & Safety in Dystonia

Benzhexol hydrochloride, an antimuscarinic agent, shows uncertain efficacy but high adverse effect risk, with potential improved daily activity participation.

Jan 26,2026  API

Thermodynamic parameters and Animal study of Lenvatinib mesylate

lenvatinib mesylate suppresses angiogenesis driven by vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF).

Jan 26,2026  API

Complexation Reaction and Applications of Chloroplatinic acid hexahydrate

Chloroplatinic acid hexahydrate serves as a metal?separating reagent, primarily used for the preparation of noble?metal catalysts and noble?metal plating.

Jan 23,2026  API

Preparation Method and Chemical Applications of CHES-2-Cyclohexylaminoethanesulfonic Acid

CHES-2-Cyclohexylaminoethanesulfonic Acid exhibits exceptionally high affinity for the iodoacetate-binding site of liver alcohol dehydrogenase.

Jan 23,2026  API

Capecitabine:Uses, Mechanism, Pharmacogenetics and side effects

Capecitabine, sold under the brand name Xeloda among others, is an anticancer medication used to treat breast cancer, gastric cancer and colorectal cancer.

Jan 22,2026  API

Ezetimibe: Indications, Interactions and Side Effects

Ezetimibe can help lower the amount of low-density lipoprotein or LDL ("bad" cholesterol) in human blood. This article will introduce its indications, interactions and side effects.

Jan 22,2026  API

Synthesis and Extraction Method of Tetrapropylammonium bromide

Tetrapropylammonium bromide is primarily used as a phase-transfer catalyst, frequently employed to catalyze heterogeneous organic chemical reactions.

Jan 22,2026  API

Preparation Methods and Thermodynamic properties of Ammonium sulfamate

Ammonium sulfamate is an inorganic compound that can be produced by the reaction of urea with sulfuric acid.

Jan 22,2026  API

Synthetic Methods and Pharmaceutical Applications of 4-Acetyl-2-methylbenzoic acid

4-Acetyl-2-methylbenzoic acid can be prepared from o-bromotoluene via Friedel–Crafts acylation followed by carbonylation.

Jan 21,2026  API
Prev12345678910...Next>  Go to Page